Titre : Catéchine

Catéchine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prognosis

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment mesurer les niveaux de catéchines dans le corps ?

Les niveaux de catéchines peuvent être mesurés par des analyses sanguines ou urinaires.
Catéchines Analyse sanguine
#2

Quels tests sont utilisés pour évaluer l'impact des catéchines ?

Des tests cliniques et des études d'observation sont utilisés pour évaluer leur impact.
Catéchines Études cliniques

Symptômes 2

#1

Quels sont les effets secondaires des catéchines ?

Les effets secondaires peuvent inclure des maux d'estomac, des nausées ou des maux de tête.
Effets secondaires Catéchines
#2

Les catéchines provoquent-elles des allergies ?

Les allergies aux catéchines sont rares, mais peuvent survenir chez certaines personnes.
Allergies Catéchines

Prévention 2

#1

Les catéchines aident-elles à prévenir les maladies cardiaques ?

Oui, elles peuvent réduire le risque de maladies cardiaques en améliorant la santé vasculaire.
Maladies cardiaques Prévention
#2

Comment intégrer les catéchines dans l'alimentation ?

Consommer du thé vert, des fruits et des légumes riches en catéchines est recommandé.
Alimentation Catéchines

Traitements 2

#1

Les catéchines peuvent-elles traiter des maladies ?

Elles sont étudiées pour leur potentiel dans le traitement de maladies comme le cancer.
Traitement du cancer Catéchines
#2

Comment les catéchines aident-elles à la perte de poids ?

Elles peuvent augmenter le métabolisme et favoriser la combustion des graisses.
Perte de poids Métabolisme

Complications 2

#1

Les catéchines peuvent-elles interagir avec des médicaments ?

Oui, elles peuvent interagir avec certains médicaments, notamment les anticoagulants.
Interactions médicamenteuses Catéchines
#2

Quels risques sont associés à une consommation excessive de catéchines ?

Une consommation excessive peut entraîner des problèmes hépatiques ou des troubles digestifs.
Toxicité Catéchines

Facteurs de risque 2

#1

Qui devrait éviter les catéchines ?

Les personnes ayant des problèmes hépatiques ou des allergies doivent être prudentes.
Facteurs de risque Catéchines
#2

Les femmes enceintes peuvent-elles consommer des catéchines ?

Elles doivent consulter un médecin avant de consommer des catéchines en grande quantité.
Grossesse Catéchines
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Catéchine : Questions médicales les plus fréquentes", "headline": "Catéchine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Catéchine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-14", "dateModified": "2025-02-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Catéchine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavonoïdes", "url": "https://questionsmedicales.fr/mesh/D005419", "about": { "@type": "MedicalCondition", "name": "Flavonoïdes", "code": { "@type": "MedicalCode", "code": "D005419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450" } } }, "about": { "@type": "MedicalCondition", "name": "Catéchine", "alternateName": "Catechin", "code": { "@type": "MedicalCode", "code": "D002392", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jae Sik Yu", "url": "https://questionsmedicales.fr/author/Jae%20Sik%20Yu", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea." } }, { "@type": "Person", "name": "Ki Hyun Kim", "url": "https://questionsmedicales.fr/author/Ki%20Hyun%20Kim", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea." } }, { "@type": "Person", "name": "Masaharu Shin-Ya", "url": "https://questionsmedicales.fr/author/Masaharu%20Shin-Ya", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } }, { "@type": "Person", "name": "Eriko Ohgitani", "url": "https://questionsmedicales.fr/author/Eriko%20Ohgitani", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } }, { "@type": "Person", "name": "Masaya Kawamoto", "url": "https://questionsmedicales.fr/author/Masaya%20Kawamoto", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Understanding Prognosis: Discrepancy in Prognosis Estimates Between Patients With Cirrhosis and their Hepatologists.", "datePublished": "2022-05-26", "url": "https://questionsmedicales.fr/article/35643416", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cgh.2022.04.042" } }, { "@type": "ScholarlyArticle", "name": "Prognosis of naevoid melanomas.", "datePublished": "2023-10-09", "url": "https://questionsmedicales.fr/article/37832354", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.prp.2023.154881" } }, { "@type": "ScholarlyArticle", "name": "The direct prognosis comparison of", "datePublished": "2023-06-02", "url": "https://questionsmedicales.fr/article/37268989", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40001-023-01140-4" } }, { "@type": "ScholarlyArticle", "name": "Clinicopathological characteristics and prognosis of medullary thyroid microcarcinoma: a tumor with a similar prognosis to macrocarcinoma.", "datePublished": "2023-11-28", "url": "https://questionsmedicales.fr/article/38017592", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40001-023-01534-4" } }, { "@type": "ScholarlyArticle", "name": "A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis.", "datePublished": "2023-05-19", "url": "https://questionsmedicales.fr/article/37208851", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1346-8138.16840" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "4H-1-Benzopyran-4-ones", "item": "https://questionsmedicales.fr/mesh/D002867" }, { "@type": "ListItem", "position": 7, "name": "Flavonoïdes", "item": "https://questionsmedicales.fr/mesh/D005419" }, { "@type": "ListItem", "position": 8, "name": "Catéchine", "item": "https://questionsmedicales.fr/mesh/D002392" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Catéchine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Catéchine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Catéchine", "description": "Comment mesurer les niveaux de catéchines dans le corps ?\nQuels tests sont utilisés pour évaluer l'impact des catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Prognosis#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Catéchine", "description": "Quels sont les effets secondaires des catéchines ?\nLes catéchines provoquent-elles des allergies ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Prognosis#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Catéchine", "description": "Les catéchines aident-elles à prévenir les maladies cardiaques ?\nComment intégrer les catéchines dans l'alimentation ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Prognosis#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Catéchine", "description": "Les catéchines peuvent-elles traiter des maladies ?\nComment les catéchines aident-elles à la perte de poids ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Prognosis#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Catéchine", "description": "Les catéchines peuvent-elles interagir avec des médicaments ?\nQuels risques sont associés à une consommation excessive de catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Prognosis#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Catéchine", "description": "Qui devrait éviter les catéchines ?\nLes femmes enceintes peuvent-elles consommer des catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Prognosis#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer les niveaux de catéchines dans le corps ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de catéchines peuvent être mesurés par des analyses sanguines ou urinaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'impact des catéchines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cliniques et des études d'observation sont utilisés pour évaluer leur impact." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des catéchines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des maux d'estomac, des nausées ou des maux de tête." } }, { "@type": "Question", "name": "Les catéchines provoquent-elles des allergies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les allergies aux catéchines sont rares, mais peuvent survenir chez certaines personnes." } }, { "@type": "Question", "name": "Les catéchines aident-elles à prévenir les maladies cardiaques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent réduire le risque de maladies cardiaques en améliorant la santé vasculaire." } }, { "@type": "Question", "name": "Comment intégrer les catéchines dans l'alimentation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Consommer du thé vert, des fruits et des légumes riches en catéchines est recommandé." } }, { "@type": "Question", "name": "Les catéchines peuvent-elles traiter des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont étudiées pour leur potentiel dans le traitement de maladies comme le cancer." } }, { "@type": "Question", "name": "Comment les catéchines aident-elles à la perte de poids ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent augmenter le métabolisme et favoriser la combustion des graisses." } }, { "@type": "Question", "name": "Les catéchines peuvent-elles interagir avec des médicaments ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent interagir avec certains médicaments, notamment les anticoagulants." } }, { "@type": "Question", "name": "Quels risques sont associés à une consommation excessive de catéchines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive peut entraîner des problèmes hépatiques ou des troubles digestifs." } }, { "@type": "Question", "name": "Qui devrait éviter les catéchines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des problèmes hépatiques ou des allergies doivent être prudentes." } }, { "@type": "Question", "name": "Les femmes enceintes peuvent-elles consommer des catéchines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles doivent consulter un médecin avant de consommer des catéchines en grande quantité." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 08/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Jae Sik Yu

2 publications dans cette catégorie

Affiliations :
  • School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
Publications dans "Catéchine" :

Ki Hyun Kim

2 publications dans cette catégorie

Affiliations :
  • School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
Publications dans "Catéchine" :

Masaharu Shin-Ya

2 publications dans cette catégorie

Affiliations :
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Molecular Anti-Virus Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Eriko Ohgitani

2 publications dans cette catégorie

Affiliations :
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masaya Kawamoto

2 publications dans cette catégorie

Affiliations :
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masaki Ichitani

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Anti-Virus Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Central Research Institute, ITO EN, Ltd, Shizuoka, Japan.

Makoto Kobayashi

2 publications dans cette catégorie

Affiliations :
  • Central Research Institute, ITO EN, Ltd, Shizuoka, Japan.

Takanobu Takihara

2 publications dans cette catégorie

Affiliations :
  • Central Research Institute, ITO EN, Ltd, Shizuoka, Japan.

Hitoshi Kinugasa

2 publications dans cette catégorie

Affiliations :
  • Central Research Institute, ITO EN, Ltd, Shizuoka, Japan.

Osam Mazda

2 publications dans cette catégorie

Affiliations :
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan. mazda@koto.kpu-m.ac.jp.
  • Department of Molecular Anti-Virus Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan. mazda@koto.kpu-m.ac.jp.

Chang Liu

2 publications dans cette catégorie

Affiliations :
  • Tea Science Society of China, Hangzhou, China.
Publications dans "Catéchine" :

Jian-Hui Ye

2 publications dans cette catégorie

Affiliations :
  • Tea Research Institute, Zhejiang University, Hangzhou, China.
Publications dans "Catéchine" :

Penghui Li

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Ailing Liu

2 publications dans cette catégorie

Affiliations :
  • College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Wenjun Xiao

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Jianan Huang

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Sheng Zhang

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Zhonghua Liu

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Zvezdelina Yaneva

2 publications dans cette catégorie

Affiliations :
  • Chemistry Unit, Department of Pharmacology, Animal Physiology and Physiological Chemistry, Faculty of Veterinary Medicine, Students Campus, Trakia University, 6000 Stara Zagora, Bulgaria.
Publications dans "Catéchine" :

Donika Ivanova

2 publications dans cette catégorie

Affiliations :
  • Chemistry Unit, Department of Pharmacology, Animal Physiology and Physiological Chemistry, Faculty of Veterinary Medicine, Students Campus, Trakia University, 6000 Stara Zagora, Bulgaria.
Publications dans "Catéchine" :

Sources (10000 au total)

Understanding Prognosis: Discrepancy in Prognosis Estimates Between Patients With Cirrhosis and their Hepatologists.

Patients require a clear understanding of their prognosis to make informed decisions about their care. The aim of this study was to compare the perceptions of prognosis and transplant candidacy betwee... Patients with cirrhosis and their hepatologists were prospectively recruited at an urban liver transplant center. Patients and hepatologists were asked about transplant candidacy and about how many ye... Seventy patients and 6 hepatologists were enrolled in the study. Patients were predominantly male (61.4%) and white (68.6%), with a mean MELD-Na score of 19 ± 9. There was no-slight agreement between ... Patients with cirrhosis are more optimistic and less accurate in their predictions of survival compared with hepatologists, although they are more realistic about their transplant candidacy. Aligning ...

Prognosis of naevoid melanomas.

There appear to be several variants of naevoid melanoma suspected as having different outcomes, but follow-up studies have been few. We aimed to assess the prognosis of naevoid melanomas in a multi-ce... From histopathology records we ascertained patients in the UK, Australia and Italy diagnosed with maturing naevoid melanoma (n = 65; 14; 7 respectively) and nodular/papillomatous naevoid melanoma (12;... Among UK patients, there was a non-significantly lower risk of melanoma death in maturing naevoid vs SSM, including after accounting for competing causes of death (SHR 0.40, 95% confidence interval (C... There was no significant difference in risk of death from melanomas with naevoid features, and SSM. Nodular/ papillomatous naevoid melanoma patients did not carry higher risk of death than SSM patient...

The direct prognosis comparison of

This study aims to compare the clinical outcomes after performing radical prostatectomy (RP) or low-dose-rate brachytherapy (LDR) for patients with intermediate-risk prostate cancer (IRPC).... We performed a retrospective analysis on 361 IRPC patients who underwent treatment in Peking Union Medical College Hospital from January 2014 to August 2021, of which 160 underwent RP and 201 underwen... Median follow-up was 54 months for RP and 69 months for LDR. According to log-rank test, the differences of 5-year bRFS (70.2% vs 83.2%, P = 0.003) and 8-year bRFS (63.1% vs 68.9%, P < 0.001) between ... LDR is a reasonable treatment option for IRPC patients, yielding improved bRFS and equivalent rates of cRFS, CSS and OS when compared with RP....

Clinicopathological characteristics and prognosis of medullary thyroid microcarcinoma: a tumor with a similar prognosis to macrocarcinoma.

Tumor size plays an important role in the staging and treatment of thyroid carcinoma. A tumor with a maximum diameter of 1 cm or less is referred to as microcarcinoma. It is unclear if the clinicopath... The patients with medullary thyroid carcinoma underwent radical operation at our hospital between December 2000 and January 2022 were retrospectively studied. A database was established for this study... A total of 198 patients were included. Of them, 56 and 142 with MTMC and macrocarcinoma, respectively. Few patients in the MTMC group had lateral lymph node metastasis. One hundred and seventy-eight (... Patients with MTMC have a lower risk of lateral lymph node metastasis and better disease-free survival than those with macrocarcinoma. However, there was no significant difference in the overall survi...

Potential prognosis index for m

Cholangiocarcinoma (CHOL) is a malignant tumor that originates in the extrahepatic bile duct and can extend from the hilar region to the lower end of the common bile duct. The prognosis of CHOL patien... The TCGA-CHOL dataset was applied to obtain and analyze the coexpression of 1281 m... Kaplan-Meier analysis indicated poor overall survival (OS) for the high-risk group. Two Gene Expression Omnibus (GEO) datasets (GSE89748 and GSE107943) were used to validate the risk model. The result... Our findings suggest that this model can be a prognostic indicator for CHOL patients....

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC.

Head and neck squamous cell carcinoma (HNSCC), the most common head and neck cancer, is highly aggressive and heterogeneous, resulting in variable prognoses and immunotherapeutic outcomes. Natural kil... In this study, NRGs were used to classify HNSCC from the TCGA-HNSCC and GEO cohorts. The genes were evaluated using univariate cox regression analysis based on the differential analysis of normal and ... With the TCGA-HNSCC data, we established a nomogram based on the 17-NRGs signature and a variety of clinicopathological characteristics. The low-risk group exhibited a better effect when it came to im... 17-NRGs signature and nomograms demonstrate excellent predictive performance and offer new perspectives for assessing pre-immune efficacy, which will facilitate future precision immuno-oncology resear...